Transition away from TLC while relying more on ELISA and instrumental testing methods;
Rotate and develop more ELISA tests; and
Pursue strategies, including cooperative alliances for the purchase of drug testing kits, to reduce overall testing costs.2. Jurisdictions should re-assess medication rules and enforcement policies in light of new and more sophisticated testing technologies.
Reassess medication rules and enforcement policies-largely formulated on the basis of outmoded TLC methodologies-in light of ELISA and instrumental testing methods, which can detect substances in very low concentrations;
Evaluate a medication's pharmacology (i.e., its ability to affect a horse's performance) in light of new and more sophisticated testing methods to determine whether, and to what extent, administrative action is appropriate; and
Research the role that permitted medications may play in interfering with the detection of prohibited substances.
3. The racing industry should support the development of withdrawal guidelines for commonly administered therapeutic medications.
Develop an alliance of industry stakeholders to determine if, when and how withdrawal times (or, alternatively, decision levels) can be made the standard for specific therapeutic medications;
Continue and expand research on the pharmacology of therapeutic medications; and
Develop a program for communicating proper systems for medication withdrawal and for reporting violations in a manner consistent with protecting the integrity of horse racing.4. A national, external quality assurance program for drug-testing laboratories should be established.
Monitor the performance of laboratories through oversight by a consortium of industry stakeholders, including racing commissions, laboratory analysts and national racing organizations;
Establish a list of substances to be tested for, and develop programs to document and verify the accuracy and reliability of testing methods; and
Disseminate findings to industry stakeholders and to participating laboratories to ensure full compliance with accepted testing procedures.5. Create a national organization to implement improvements in drug testing and provide leadership in jurisprudence and public communication practices relating to drug testing issues.
Form a national organization, representing regulators, owners, trainers. racetracks, veterinarians and drug testing researchers to implement recommendations outlined in the task force report;
Coordinate judicial and drug testing research efforts between states and racing jurisdictions; and
Reduce litigation relating to medication violations and increase horse racing's credibility in the area of drug testing by promoting judicially sound, "best practices" relating to public disclosure of suspected medication violations.Executive Summary of Racing Integrity and Drug Testing Task Force Report